COMP <GO>
OTEX vs EPAM // 10Y YIELD & FRED MACRO BETA
Open Text Corporation (NASDAQ) VS. EPAM Systems Inc. (NYSE) • 15-METRIC TALLY: OTEX 6
— EPAM 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: EPAM
LAST: $27.07 (-0.22%) • MKT CAP: $6.78B
macro-sensitivity
1.36
LAST: $134.70 (-1.12%) • MKT CAP: $6.95B
macro-sensitivity
1.37
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OTEX VS. EPAM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OTEX | EPAM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 72.30% | 28.80% | +43.50 | OTEX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.70% | 17.10% | -9.40 | EPAM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.9x | 10.2x | +0.70 | EPAM | /valuation <GO> |
| Free Cash Flow Yield | 8.82% | 8.82% | 0.00 | TIE | /fcf-yield <GO> |
| Operating Margin | 17.30% | 9.50% | +7.80 | OTEX | /operating-margins <GO> |
| Net Profit Margin | 8.40% | 6.90% | +1.50 | OTEX | /net-margins <GO> |
| Revenue Growth (YoY) | -10.40% | 15.40% | -25.80 | EPAM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.00% | 0.00% | +4.00 | OTEX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.41 | 5.67 | -4.26 | EPAM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | EPAM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.1 | 61.4 | +3.70 | OTEX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.36 | 1.37 | -0.01 | EPAM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.5x | 15.5x | -1.00 | OTEX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.78B | $6.95B | -$164.9M | EPAM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OTEX REV | EPAM REV | OTEX GROSS % | EPAM GROSS % | OTEX FCF | EPAM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.17B | $5.46B | 72.3% | 28.8% | $598.0M | $612.7M |
| FY 2024 | $5.77B | $4.73B | 72.6% | 30.7% | $708.1M | $527.0M |
| FY 2023 | $4.48B | $4.69B | — | — | $577.4M | $351.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OTEX // BETA 1.36
EPAM // BETA 1.37